Cybin

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cybin and other ETFs, options, and stocks.

About CYBN

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.

CEO

Eric So

CEOEric So

Employees

Employees50

Headquarters

Toronto, Ontario

HeadquartersToronto, Ontario

Founded

2016

Founded2016

Employees

Employees50

CYBN Key Statistics

Market cap

286.89M

Market cap286.89M

Price-Earnings ratio

-1.48

Price-Earnings ratio-1.48

Dividend yield

—

Dividend yield—

Average volume

596.82K

Average volume596.82K

High today

$6.07

High today$6.07

Low today

$5.75

Low today$5.75

Open price

$5.96

Open price$5.96

Volume

435.29K

Volume435.29K

52 Week high

$10.73

52 Week high$10.73

52 Week low

$4.81

52 Week low$4.81

Stock Snapshot

With a market cap of 286.89M, Cybin(CYBN) trades at $5.84. The stock has a price-to-earnings ratio of -1.48.

On 2025-12-10, Cybin(CYBN) stock traded between a low of $5.75 and a high of $6.07. Shares are currently priced at $5.84, which is +1.7% above the low and -3.8% below the high.

The Cybin(CYBN)'s current trading volume is 435.29K, compared to an average daily volume of 596.82K.

During the past year, Cybin(CYBN) stock moved between $4.81 at its lowest and $10.73 at its peak.

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CYBN. This list is generated using Robinhood data, and it’s not a recommendation.

Mind Medicine (MindMed)